Falsely elevated tacrolimus concentrations measured using the ACMIA method due to circulating endogenous antibodies in a kidney transplant recipient

Clinica Chimica Acta

Volumn 412, Issue 3-4, 2011, Pages 245-248

  D'Alessandro, Mariadomenica ^a   Mariani, Paola ^a   Mennini, Gianluca ^a   Severi, Danilo ^a   Berloco, Pasquale ^a   Bachetoni, Alessandra ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

ACMIA; Assay interference; False positive; Tacrolimus; Therapeutic drug monitoring

Indexed keywords

ANTIBODY; BASILIXIMAB; BETA GALACTOSIDASE; CORTICOSTEROID; TACROLIMUS;

ADULT; ANTIBODY CONJUGATED MAGNETIC IMMUNOASSAY; ARTICLE; BLOOD SAMPLING; CASE REPORT; DEATH; DETERIORATION; DILUTION; DRUG MONITORING; GRAFT RECIPIENT; HUMAN; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LITHOTRIPSY; MALE; NEPHROLITHIASIS; PRIORITY JOURNAL;

EID: 78650234794     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.10.026     Document Type: Article

References (18)

1. Wallemacq P., Armstrong V.W., Brunet M., et al. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Ther Drug Monit 2009, 31:139-152.
2. Bachetoni A., Mariani P., D'Alessandro M., et al. Preliminary evaluation of the new TACR flex method versus MEIA method in the therapeutic monitoring of tacrolimus in organ transplantation. Transplant Proc 2007, 39:2008-2009.
3. Akbas S.H., Ozdem S., Caglar S., et al. Effects of some haematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods. Clin Biochem 2005, 38:552-557.
4. Zhang Y., Benet L.Z. The gut as barrier to drug absorption: combined role of cytochrome P450 3A and P-Glycoprotein. Clin Pharmacokinet 2001, 40:159-168.
5. Iwasaki K. Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics. Drug Metab Pharmacokinet 2007, 22:328-335.
6. Freire A., Hermida J., Tutor J.C. Comparison of blood tacrolimus concentrations in liver and kidney transplant recipients using ACMIA and MEIA immunoassays. Ups J Med Sci 2008, 113:103-110.
7. Ismail A.A. Interference from endogenous antibodies in automated immunoassays: what laboratorians need to know. J Clin Pathol 2009, 62:673-678.
8. Boscato L.M., Stuart M.C. Heterophilic antibodies: a problem for all immunoassays. Clin Chem 1988, 34:27-33.
9. Kricka L.J. Human anti-animal antibody interferences in immunological assays. Clin Chem 1999, 45:942-956.
10. Altinier S., Varagnolo M., Zaninotto M., Boccagni P., Plebani M. Heterophilic antibody interference in a non-endogenous molecule assay: an apparent elevation in the tacrolimus concentration. Clin Chim Acta 2009, 402:193-195.
11. Parikh B.A., Siedlecki A.M., Scott M.G. Specificity of a circulating antibody that interferes with a widely used tacrolimus immunoassay. Ther Drug Monit 2010, 32:228-231.
12. Tacrolimus 2008, Siemens Healthcare, Newark, DE, (Package insert).
13. Tacrolimus II: IMx System. Ref 3C10, 34-3782/R7. Abbott Park, Ill Abbott Laboratories.
14. Koster R.A., Dijkers E.C., Uges D.R. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood. Ther Drug Monit 2009, 31:116-125.
15. Holt D.W., Armstrong V.W., Griesmacher A., et al. International federation of clinical chemistry/international association of therapeutic drug monitoring and clinical toxicology working group on immunosuppressive drug monitoring. Ther Drug Monit 2002, 24:59-67.
16. Hermida J., Tutor J.C. Falsely increased blood tacrolimus concentrations using the ACMIA assay due to circulating endogenous antibodies in a liver transplant recipient: a tentative approach to obtaining reliable results. Ther Drug Monit 2009, 31:269-272.
17. Barau C., Frangie C., Goujard C., et al. Falsely elevated whole blood tacrolimus concentrations due to interference in an affinity column-mediated immunoassay method on Xpand Dimension. Ther Drug Monit 2009, 31:267-268.
18. Moscato D., Nonnato A., Adamo R., Vancheri M., Caropreso A. Therapeutic monitoring of tacrolimus: aberrant results by an immunoassay with automated pretreatment. Clin Chim Acta 2010, 411:77-80.